Cardiovascular Disease, Cancer, and Multimorbidity Interactions: Clinical Implications
Cardiology · 2022 · 147 (2) · 196-206
DOI: 10.1159/000521680 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiology, online erschienen am 05.01.2022. Verfasst von Konstantinos Dean Boudoulas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Background: With the aging population, the frequency of cardiovascular disease (CVD), cancer, and other morbid conditions is increasing dramatically. In addition, one disease may affect the other leading to a vicious cycle. Summary: With aging, the function of organs and systems of the human body declines including the immune system resulting in a diminished response to various pathogens and a chronic inflammatory process; these changes, in addition to other risk factors, contribute to the development of multiple morbid conditions including CVD and cancer. Multimorbidity in the elderly has become the rule rather than the exception today. Further, this association between CVD and cancer, at least partially, is explained by both diseases sharing common risk factors and from accelerated vascular aging due to cancer and its associated therapies. Multiple studies have shown that the incidence of cancer is much higher in patients with CVD compared to the general population. These associations among CVD, cancer, and their connection to systems of the human body provide an opportunity for novel therapies. Development of new drugs should be addressed to focus on multiple systems and not just only to one disease. Further, collecting information from registries and processing large amounts of data using artificial intelligence may assist the clinician when treating an individual patient in the future. Key Messages: As the aging population increases, CVD, cancer, and multimorbidity will continue to constitute a major health problem in the years to come. The physician who is taking care of such a patient, in addition to knowledge, requires clinical wisdom, clinical experience, and common sense in order to apply the continuous evolving knowledge to the individual patient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, The Ohio State University, Columbus, Ohio, USA.
- Department of Cardiology, Larissa University General Hospital, Larissa, Greece.
- Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Biomedical Research Foundation, Academy of Athens, Athens, Greece.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Boudoulas, K. D., Triposkiadis, F., Gumina, R., Addison, D., Iliescu, C., & Boudoulas, H. (2022). Cardiovascular Disease, Cancer, and Multimorbidity Interactions: Clinical Implications. Cardiology, 147(2), 196-206. https://doi.org/10.1159/000521680
Vancouver
Boudoulas KD, Triposkiadis F, Gumina R, Addison D, Iliescu C, Boudoulas H. Cardiovascular Disease, Cancer, and Multimorbidity Interactions: Clinical Implications. Cardiology. 2022;147(2):196-206. doi:10.1159/000521680
BibTeX
@article{Boudoulas2022,
author = {Boudoulas, Konstantinos Dean and Triposkiadis, Filippos and Gumina, Richard and Addison, Daniel and Iliescu, Cezar and Boudoulas, Harisios},
title = {Cardiovascular Disease, Cancer, and Multimorbidity Interactions: Clinical Implications},
journal = {Cardiology},
year = {2022},
volume = {147},
number = {2},
pages = {196--206},
doi = {10.1159/000521680}
}
EUVIMED